These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 13104331)

  • 1. Primary cardiac amyloidosis.
    THOMASHOW AI; ANGLE WD; MORRIONE TG
    Am Heart J; 1953 Dec; 46(6):895-905. PubMed ID: 13104331
    [No Abstract]   [Full Text] [Related]  

  • 2. [Primary cardiac amyloidosis].
    GRAVANO L
    Dia Med; 1960 Nov; 32():2497-506. PubMed ID: 13707997
    [No Abstract]   [Full Text] [Related]  

  • 3. [PRIMARY CARDIAC AMYLOIDOSIS].
    KIMURA N; MORI I; AZUMA A; KAMEO H; ENDO T; YOSINAGA M; SIMOKAWA Y
    Nihon Naika Gakkai Zasshi; 1964 Feb; 52():1365-7. PubMed ID: 14156211
    [No Abstract]   [Full Text] [Related]  

  • 4. [Amyloidosis of the heart; a case of primary atypical amyloidosis exclusively localized to the heart].
    FREDERIKSEN T
    Ugeskr Laeger; 1955 Jun; 117(22):720-3. PubMed ID: 13247467
    [No Abstract]   [Full Text] [Related]  

  • 5. [Primary cardiac amyloidosis; case report].
    FONGI E; MOSSO HE; PEROSIO A; CAMPOS A; OBARRIO A; BAS FIGUEROA C
    Prensa Med Argent; 1957 Jan; 44(3):163-7. PubMed ID: 13453179
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary amyloidosis of the heart.
    COELHO E; PIMENTEL JC
    Ciba Symp (1956); 1962; 10():2-11. PubMed ID: 13880137
    [No Abstract]   [Full Text] [Related]  

  • 7. The heart in primary systemic amyloid disease.
    LINDSAY S
    Mod Concepts Cardiovasc Dis; 1948 Jun; 17(6):1. PubMed ID: 18865568
    [No Abstract]   [Full Text] [Related]  

  • 8. Familial primary amyloidosis with severe amyloid heart disease.
    FREDERIKSEN T; GOTZSCHE H; HARBOE N; KIAER W; MELLEMGAARD K
    Am J Med; 1962 Sep; 33():328-48. PubMed ID: 13894830
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary amyloidosis; a report of two cases.
    JACKSON A; SLAVIN M
    Am Heart J; 1954 Jun; 47(5):839-44. PubMed ID: 13158267
    [No Abstract]   [Full Text] [Related]  

  • 10. Should We Expand Cardiac Response Criteria in Patients with Light Chain Cardiac Amyloidosis?
    López-Ibor JV; Krsnik I; Gómez-Bueno M; Hernández-Pérez FJ; Durante-López A; Mingo Santos S; Moñivas Palomero V; García-Izquierdo E; Sayago I; Royuela A; Segovia-Cubero J
    J Am Soc Echocardiogr; 2021 Mar; 34(3):318-322. PubMed ID: 33276078
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of implantable intracardiac defibrillators in patients with cardiac immunoglobulin light chain amyloidosis.
    Rezk T; Whelan CJ; Lachmann HJ; Fontana M; Sachchithanantham S; Mahmood S; Khan F; Khiani R; Tomson J; Youngstein T; Gillmore JD; Hawkins PN; Wechalekar AD
    Br J Haematol; 2018 Jul; 182(1):145-148. PubMed ID: 28485005
    [No Abstract]   [Full Text] [Related]  

  • 12. Life-saving implantable cardioverter defibrillator therapy in cardiac AL amyloidosis.
    Patel KS; Hawkins PN; Whelan CJ; Gillmore JD
    BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25535224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial for "Non-enhanced Chemical Exchange Saturation Transfer Cardiac Magnetic Resonance Imaging in Patients With Amyloid Light Chain Amyloidosis".
    Winter PM
    J Magn Reson Imaging; 2022 Feb; 55(2):577-578. PubMed ID: 34296801
    [No Abstract]   [Full Text] [Related]  

  • 14. A first step beyond traditional boundaries: destination therapy with the SynCardia total artificial heart.
    Spiliopoulos S; Koerfer R; Tenderich G
    Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):855-6. PubMed ID: 24632422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Standard Echocardiographic Parameters in Endomyocardial Biopsy Proven Cardiac Amyloidosis.
    Biočić S; Jurinjak SJ; Vincelj J; Barić D; Manojlović S; Brkljačić DD
    Coll Antropol; 2015 Jun; 39(2):441-5. PubMed ID: 26753463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grading cardiac response in AL amyloidosis: implications for relapse and survival.
    Eckhert E; Witteles R; Kaufman G; Lafayette R; Arai S; Schrier S; O'Shaughnessy M; Liedtke M
    Br J Haematol; 2019 Jul; 186(1):144-146. PubMed ID: 30569572
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance study.
    Mohty D; Boulogne C; Magne J; Varroud-Vial N; Martin S; Ettaif H; Fadel BM; Bridoux F; Aboyans V; Damy T; Jaccard A
    Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):961-9. PubMed ID: 27194782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac amyloidosis: where are we today?
    Patel KS; Hawkins PN
    J Intern Med; 2015 Aug; 278(2):126-44. PubMed ID: 26077367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WEEKLY clinicopathological exercises: primary amyloidosis of heart with cardiac failure.
    N Engl J Med; 1952 Feb; 246(8):302-5. PubMed ID: 14899634
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of clinical and echocardiographic characteristics on occurrence of cardiac events in cardiac amyloidosis as proven by endomyocardial biopsy.
    Nakahashi T; Arita T; Yamaji K; Inoue K; Yokota T; Hoshii Y; Fukunaga M; Nomura A; Watanabe H; Miura S; Isotani A; Soga Y; Ando K; Iwabuchi M; Yokoi H; Nosaka H; Yamagishi M; Nobuyoshi M
    Int J Cardiol; 2014 Oct; 176(3):753-9. PubMed ID: 25131905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.